Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018
Malar. j. (Online); 20 (1), 2021
Background: Due to the threat of emerging anti-malarial resistance, the World Health Organization recommends incorporating surveillance for molecular markers of anti-malarial resistance into routine therapeutic efficacy studies (TESs). In 2018, a TES of artemether-lumefantrine (AL) and artesunate-amodiaq...
Antimalarials/pharmacology, Antimalarials/therapeutic use, Artemisinins/pharmacology, Artemisinins/therapeutic use, Drug Resistance/genetics, Drug Therapy, Combination, Genetic Markers, Plasmodium falciparum/radiation effects, Plasmodium falciparum/genetics, Plasmodium falciparum/isolation & purification, Polymorphism, Genetic/genetics, Mozambique